Technical Analysis for NMRD - Nemaura Medical Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Narrow Range Bar | Range Contraction | 5.43% | |
Earnings Movers | Other | 5.43% | |
Inside Day | Range Contraction | 5.43% | |
Wide Bands | Range Expansion | 5.43% | |
180 Bearish Setup | Bearish Swing Setup | 7.54% | |
Volume Surge | Other | 7.54% | |
Earnings Movers | Other | 7.54% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | 1 day ago |
10 DMA Resistance | 1 day ago |
Rose Above 10 DMA | 1 day ago |
Up 5% | 1 day ago |
Up 3% | 1 day ago |
Get a Trading Sidekick!
- Earnings date: 05/29/2024
Nemaura Medical Inc. Description
Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Device Glucose Endocrine System Blood Test Wireless Devices Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology Type I Diabetes Blood Sugar Level Continuous Glucose Monitor Type II Diabetes
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.25 |
52 Week Low | 0.0292 |
Average Volume | 41,393 |
200-Day Moving Average | 0.19 |
50-Day Moving Average | 0.06 |
20-Day Moving Average | 0.04 |
10-Day Moving Average | 0.05 |
Average True Range | 0.01 |
RSI (14) | 50.98 |
ADX | 28.06 |
+DI | 24.38 |
-DI | 13.28 |
Chandelier Exit (Long, 3 ATRs) | 0.03 |
Chandelier Exit (Short, 3 ATRs) | 0.06 |
Upper Bollinger Bands | 0.06 |
Lower Bollinger Band | 0.02 |
Percent B (%b) | 0.68 |
BandWidth | 82.19 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.002 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.06 | ||||
Resistance 3 (R3) | 0.06 | 0.05 | 0.05 | ||
Resistance 2 (R2) | 0.05 | 0.05 | 0.05 | 0.05 | |
Resistance 1 (R1) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Pivot Point | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Support 1 (S1) | 0.05 | 0.05 | 0.04 | 0.05 | 0.04 |
Support 2 (S2) | 0.04 | 0.05 | 0.04 | 0.04 | |
Support 3 (S3) | 0.04 | 0.04 | 0.04 | ||
Support 4 (S4) | 0.04 |